Duke University Hospital Pediatric Infectious Diseases

Topics

• Antifungal resistance and susceptibility 260
• HIV Research and Treatment 133
• Ocular Oncology and Treatments 98
• Influenza Virus Research Studies 84
• Neonatal and Maternal Infections 73
• Glioma Diagnosis and Treatment 68
• HIV/AIDS Research and Interventions 68
• Antimicrobial Resistance in Staphylococcus 55
• Cytomegalovirus and herpesvirus research 53
• SARS-CoV-2 and COVID-19 Research 51
• Antibiotics Pharmacokinetics and Efficacy 50
• Pharmaceutical studies and practices 49

Most cited

1. Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.

   The New England journal of medicine · 2021 · 967 citations · Miriam Cameron

2. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.

   JAMA network open · 2021 · 778 citations · Jessica Ericson

3. Diverse functional autoantibodies in patients with COVID-19.

   Nature · 2021 · 775 citations · Melissa Campbell

4. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

   The New England journal of medicine · 2021 · 698 citations · Emmanuel Walter

5. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

   The New England journal of medicine · 2022 · 477 citations · Emmanuel Walter

6. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

   The Lancet. Infectious diseases · 2025 · 69 citations · Barbara Alexander

7. Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.